1.94% -0.055

Evotec Se Adr (EVO)

Überblick Nachrichten Preisverlauf Warum fällt EVO? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Evotec Se Adr Stock (EVO) Company Profile

Evotec Se Adr

Healthcare (1096)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

EVO's Discussions on Twitter

Compare EVO vs TAK, HLN, TEVA, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
EVO Evotec Se Adr	2.785	989.20M	863.66M	-225.27M	-63.28M	-0.6342
TAK Takeda Pharmaceutical Co Adr	16.56	52.88B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.76	42.98B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	32.95	38.37B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	75.56	31.68B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	547.06	23.22B	3.17B	1.29B	1.01B	27.09

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-15	Fortgesetzt	H.C. Wainwright	Buy
2026-02-03	Eingeleitet	Berenberg	Buy
2025-04-24	Hochstufung	Deutsche Bank	Sell → Hold
2024-10-07	Herabstufung	Jefferies	Buy → Hold
2024-08-08	Herabstufung	Deutsche Bank	Hold → Sell
2024-07-29	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-07-11	Herabstufung	Deutsche Bank	Buy → Hold
2024-04-12	Hochstufung	Deutsche Bank	Hold → Buy
2024-01-18	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2023-06-23	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-06-16	Herabstufung	BofA Securities	Buy → Neutral
2023-06-08	Hochstufung	Citigroup	Neutral → Buy
2023-04-04	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2022-12-09	Eingeleitet	H.C. Wainwright	Buy
2022-11-16	Herabstufung	Deutsche Bank	Buy → Hold
2022-08-10	Herabstufung	Morgan Stanley	Overweight → Underweight
2022-03-02	Fortgesetzt	Cowen	Outperform
2022-01-07	Fortgesetzt	Citigroup	Neutral

Alle ansehen

Evotec Se Adr Aktie (EVO) Neueste Nachrichten

Finanzdaten der Evotec Se Adr-Aktie (EVO)

Evotec Se Adr (EVO)

Evotec Se Adr Stock (EVO) Company Profile

Compare EVO vs TAK, HLN, TEVA, ZTS, UTHR

Evotec Se Adr Stock (EVO) Upgrades & Downgrades

Evotec Se Adr Aktie (EVO) Neueste Nachrichten

Evotec stock. Thin source set keeps the focus on business context. - ad-hoc-news.de

EVTA Forecast — Price Target — Prediction for 2027 - TradingView

100% Profit Potential in Sight: Vidac Pharma's Chance to Double vs Bayer and Evotec - news.financial

Weight-Loss Injections, Cancer Cell Inhibitors & the Power of Algorithms: Adding Potential to Your Portfolio with Novo Nordisk, Vidac Pharma, and Evotec - news.financial

Evotec consensus picture on Wall Street, shares trade as ADR on NASDAQ - ad-hoc-news.de

Evotec launches J.TRAIN for biologics manufacturing - grafa.com

Evotec consensus picture on Nasdaq EVO, shares hover around 2.74 dollars - ad-hoc-news.de

A0QZ3J Forecast — Price Target — Prediction for 2027 - TradingView

Evotec SE Sponsored ADR Actuals & Estimates (NASDAQ:EVO) - TradingView

Evotec refines analyst expectations, shares trade under 5 euros on Xetra - AD HOC NEWS

Evotec shows weak June performance, analyst consensus points above current shares - AD HOC NEWS

Evotec Stockweekly review and sector comparison - Ad-hoc-news.de

Which stock to buy now? Evotec, Nel, and Lahontan Gold in focus - news.financial

Evotec (EVO) Stock Price, News & Analysis $EVO - MarketBeat

Evotec SE Stock (DE0005664809): Short Interest Eases While Shares Trade Near Lows - AD HOC NEWS

Earnings call transcript: Evotec Q1 2026 sees revenue drop amid market challenges - Investing.com

Evotec Q1 2026 slides: revenue drops 22% as transformation accelerates - Investing.com

Evotec reports wider quarterly loss, misses revenue expectations By Investing.com - Investing.com Nigeria

Evotec SE stock (DE0005664809): After CEO exit and audit delay, investors watch turnaround plans - AD HOC NEWS

EVOEvotec SE ADR Stock Price and Quote - Finviz

Evotec ADR Slides 4.3% as Selling Pressure Tests Key Support LevelsQuality Factor - The Legal Advocate

Takeover Candidates for 2026! The Life Sciences Sector Is Heating Up: Evotec, BioNxt Solutions, BioNTech, and Formycon in Focus! - news.financial

BUY RECOMMENDATIONS for RENK and Desert Gold! SHOCK for Evotec! - news.financial

Evotec SE stock (DE0005664809): Steady FY 2025 results amid US expansion - AD HOC NEWS

Evotec AG Earnings Call Balances Pain With Promise - The Globe and Mail

Evotec SE stock (DE0005664809): Drug discovery leader eyes US biotech growth - AD HOC NEWS

Evotec places €116.1 million convertible bonds due 2033 - Investing.com UK

Evotec places €116.1 million convertible bonds due 2033 By Investing.com - Investing.com South Africa

Evotec SE stock (DE0005664809): Recent price gains signal short-term momentum - AD HOC NEWS

Evotec SE stock (DE0005664809): HC Wainwright cuts Q2 earnings outlook - AD HOC NEWS

Boyd Gaming posts downbeat Q1 results, joins Coursera, Evotec and other big stocks moving lower in Friday's pre-market session - MSN

Evotec SE stock (DE0005664809): Q1 2026 results show sharp revenue drop amid restructuring - AD HOC NEWS

Take note! The stock market is (still) ignoring key developments at Desert Gold, Evotec, and Mutares! - news.financial

Evotec Q1 2026 slides: revenue drops 22% as transformation accelerates By Investing.com - Investing.com Nigeria

Earnings call transcript: Evotec Q1 2026 sees revenue drop amid market challenges By Investing.com - Investing.com South Africa

Evotec reports wider quarterly loss, misses revenue expectations - Investing.com

Evotec's Share Price Surges! Summer Rally for Desert Gold? Rheinmetall Shares Heading Toward EUR 2,000? - news.financial

Evotec & Almirall nominate dermatology development candidate - grafa.com

Evotec SE Stock (DE0005664809): Q1 2026 Results Due Today - AD HOC NEWS

Finanzdaten der Evotec Se Adr-Aktie (EVO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie EVO